Notably, patients with a preoperative L3SMI above the 75th percentile (>40.0375 cm 2 /m 2 ) of all patients showed a clear trend toward improved postoperative overall survival, when compared to the other patients (1435 (95% CI: 0–3222) days vs. 473 (95% CI: 218–728) days and 403 (95% CI: 109–697) days; log rank X 2 (2) = 5.303, p = 0.071; Figure 4 B).
← all excerpts
Sarcopenia Predicts Cancer Mortality in Male but Not in Female Patients Undergoing Surgery for Cholangiocellular Carcinoma.
1
—
—